Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pak J Pharm Sci ; 20(3): 199-202, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17545104

RESUMEN

Eggs were collected from different areas of Faisalabad city. The quantity of sulphonamides was determined in yolk, white and whole egg and compared with the permissible limit 1 microg/ml for sulphadimethoxine available in literature. In another experiment, a group of hens were kept at a poultry farm after medicating them with darvisal liquid to see if the residues of sulphonamide pass into the eggs of poultry. The period of existence of residues was noted.


Asunto(s)
Antiinfecciosos/análisis , Pollos/metabolismo , Residuos de Medicamentos/análisis , Huevos/análisis , Contaminación de Alimentos/análisis , Sulfonamidas/análisis , Animales , Antiinfecciosos/farmacocinética , Clara de Huevo/análisis , Yema de Huevo/química , Femenino , Pakistán , Sulfadimetoxina/análisis , Sulfaquinoxalina/farmacocinética , Sulfonamidas/farmacocinética
2.
Aust Vet J ; 79(2): 120-4, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11256283

RESUMEN

OBJECTIVE: To assess the efficacy of four macrocyclic lactones for the control of larvae of the Old World Screw-worm Fly (OWS), Chrysomya bezziana, and to examine the effects of excreted residues on the dung fauna. ANIMALS: 100 heifers were divided into five groups of 20 animals. One group remained untreated, whereas the other groups were treated respectively with pour-on formulations of moxidectin, eprinomectin or doramectin, or a sustained-release bolus of ivermectin. PROCEDURES: At intervals of 1 to 15 weeks after treatment, five cattle from each group were challenged with newly-laid eggs of OWS. The efficacy of each treatment was determined 48 h later by comparing the number of myiases in the treated and untreated groups. Abundance of fly larvae in naturally-voided dung pads and the survival of a species of dung beetle, Onthophagus sagittarius, were used to assess the effects of drug residues on the dung fauna. RESULTS AND CONCLUSIONS: Moxidectin showed no activity against larvae of OWS during the first 14 days after treatment. Eprinomectin provided protection for 3 days after dosing, but failed at days 7 and 14, whereas doramectin was effective at day 7, but not at days 14 or 21. In contrast, no myiases were established on bolus-treated cattle from 14 to 102 days after treatment. Faecal residues of moxidectin had no effect on the survival of larvae of dung-feeding flies, whereas those of eprinomectin and doramectin reduced survival for 1 to 2 weeks. Dung voided by bolus-treated cattle inhibited fly breeding and had adverse effects on the development and survival of O sagittarius for up to 15 weeks after treatment.


Asunto(s)
Enfermedades de los Bovinos/prevención & control , Dípteros , Insecticidas/uso terapéutico , Ivermectina/análogos & derivados , Miasis/veterinaria , Animales , Antibacterianos/uso terapéutico , Bovinos , Residuos de Medicamentos/análisis , Heces/parasitología , Femenino , Ivermectina/uso terapéutico , Larva , Macrólidos , Masculino , Miasis/prevención & control
3.
Jpn J Cancer Res ; 80(2): 111-4, 1989 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2498245

RESUMEN

Serum pepsinogen levels were measured in 137 stomach cancer patients and compared with those of 288 normal cancer-free subjects. The serum pepsinogen levels of stomach cancer patients, especially pepsinogen I and the pepsinogen I/pepsinogen II ratio were significantly lower than those of normal controls and correlated well with the extent of chronic gastritis associated with the cancerous stomach. These results were in good accordance with the results of previous studies indicating that the cancer derived from the stomach where chronic gastritis/intestinal metaplasia is extensive. The high sensitivity and specificity of this non-invasive serum test to detect chronic gastritis suggested the possibility of its application to the mass screening of stomach cancer.


Asunto(s)
Gastritis/complicaciones , Pepsinógenos/sangre , Neoplasias Gástricas/diagnóstico , Adenocarcinoma/sangre , Envejecimiento , Unión Competitiva , Enfermedad Crónica , Femenino , Gastritis/sangre , Humanos , Intestinos/patología , Masculino , Metaplasia , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Radioinmunoensayo , Estómago/patología , Neoplasias Gástricas/sangre , Neoplasias Gástricas/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA